Page last updated: 2024-09-05

orantinib and bafilomycin a1

orantinib has been researched along with bafilomycin a1 in 1 studies

Compound Research Comparison

Studies
(orantinib)
Trials
(orantinib)
Recent Studies (post-2010)
(orantinib)
Studies
(bafilomycin a1)
Trials
(bafilomycin a1)
Recent Studies (post-2010) (bafilomycin a1)
11019361,1201484

Protein Interaction Comparison

ProteinTaxonomyorantinib (IC50)bafilomycin a1 (IC50)
P2X purinoceptor 3Homo sapiens (human)0.755
V-type proton ATPase subunit S1Homo sapiens (human)0.1
Vacuolar proton pump subunit B Gallus gallus (chicken)0.03

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, X; Hara, M; Ikeda, S; Kamijo, S; Kawasaki, J; Ogawa, H; Okumura, K; Takai, T; Ushio, H; Vu, AT; Xie, Y1

Other Studies

1 other study(ies) available for orantinib and bafilomycin a1

ArticleYear
Extracellular double-stranded RNA induces TSLP via an endosomal acidification- and NF-κB-dependent pathway in human keratinocytes.
    The Journal of investigative dermatology, 2011, Volume: 131, Issue:11

    Topics: Cells, Cultured; Cytokines; Endosomes; Humans; Indoles; Interferon Regulatory Factor-3; Interferon-beta; Interleukin-8; Keratinocytes; Macrolides; NF-kappa B; Oxindoles; Poly I-C; Propionates; Pyrroles; RNA, Double-Stranded; RNA, Small Interfering; Signal Transduction; Thymic Stromal Lymphopoietin; Toll-Like Receptor 3; Transcription Factor RelA

2011